Brave Asset Management’s Zimmer Biomet ZBH Stock Holding History

Brave Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-309	Closed	-$39K	–	340
2016 Q3	$39K	Hold	309	–	–	0.03%	240
2016 Q2	$36K	Hold	309	–	–	0.02%	248
2016 Q1	$32K	Hold	309	–	–	0.02%	258
2015 Q4	$31K	Hold	309	–	–	0.02%	264
2015 Q3	$28K	Hold	309	–	–	0.02%	261
2015 Q2	$33K	Hold	309	–	–	0.02%	265
2015 Q1	$35K	Hold	309	–	–	0.02%	257
2014 Q4	$34K	Hold	309	–	–	0.02%	256
2014 Q3	$30K	Hold	309	–	–	0.02%	265
2014 Q2	$31K	Hold	309	–	–	0.02%	264
2014 Q1	$28K	Hold	309	–	–	0.02%	268
2013 Q4	$28K	Buy	+309	New	+$26.7K	0.02%	256

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Brave Asset Management's ZBH Position: Q4 2016 in Review

Brave Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 309 shares — an estimated $39K sold.

Brave Asset Management first reported a position in ZBH in Q4 2013 and held it in 12 quarters. The position peaked at $39K in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

Brave Asset Management reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 309 Zimmer Biomet shares in Q4 2016, an estimated $39K.
Brave Asset Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 12 quarters.
Brave Asset Management's Zimmer Biomet position peaked at $39K in Q3 2016.
812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.